Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs midazolam sedation in invasively ventilated ICU patients with severe pneumonia
ChiCTR2500102494Phase 4Not yet recruiting
- Sponsor
- Anhui Chest Hospital
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in pneumonia (2 arms), sponsored by Anhui Chest Hospital. Primary endpoint: RASS score. Planned start May 2025; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
pneumonia
Beyond the preview
Go deeper on ChiCTR2500102494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500102494.